These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 11022045

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Regulated Co-translational ubiquitination of apolipoprotein B100. A new paradigm for proteasomal degradation of a secretory protein.
    Zhou M, Fisher EA, Ginsberg HN.
    J Biol Chem; 1998 Sep 18; 273(38):24649-53. PubMed ID: 9733761
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Proteasome-mediated degradation of apolipoprotein B targets both nascent peptides cotranslationally before translocation and full-length apolipoprotein B after translocation into the endoplasmic reticulum.
    Liao W, Yeung SC, Chan L.
    J Biol Chem; 1998 Oct 16; 273(42):27225-30. PubMed ID: 9765244
    [Abstract] [Full Text] [Related]

  • 5. Efficient glycosylation site utilization by intracellular apolipoprotein B. Implications for proteasomal degradation.
    Huang XF, Shelness GS.
    J Lipid Res; 1999 Dec 16; 40(12):2212-22. PubMed ID: 10588947
    [Abstract] [Full Text] [Related]

  • 6. Effects of tocotrienol on the intracellular translocation and degradation of apolipoprotein B: possible involvement of a proteasome independent pathway.
    Wang Q, Theriault A, Gapor A, Adeli K.
    Biochem Biophys Res Commun; 1998 May 29; 246(3):640-3. PubMed ID: 9618265
    [Abstract] [Full Text] [Related]

  • 7. Translocational status of ApoB in the presence of an inhibitor of microsomal triglyceride transfer protein.
    Macri J, Kazemian P, Kulinski A, Rudy D, Aiton A, Thibert RJ, Adeli K.
    Biochem Biophys Res Commun; 2000 Oct 05; 276(3):1035-47. PubMed ID: 11027587
    [Abstract] [Full Text] [Related]

  • 8. 2000 George Lyman Duff Memorial Lecture: atherosclerosis is a liver disease of the heart.
    Davis RA, Hui TY.
    Arterioscler Thromb Vasc Biol; 2001 Jun 05; 21(6):887-98. PubMed ID: 11397693
    [Abstract] [Full Text] [Related]

  • 9. Cytosolic components are required for proteasomal degradation of newly synthesized apolipoprotein B in permeabilized HepG2 cells.
    Sakata N, Stoops JD, Dixon JL.
    J Biol Chem; 1999 Jun 11; 274(24):17068-74. PubMed ID: 10358059
    [Abstract] [Full Text] [Related]

  • 10. Ubiquitin-dependent and -independent proteasomal degradation of apoB associated with endoplasmic reticulum and Golgi apparatus, respectively, in HepG2 cells.
    Liao W, Chang BH, Mancini M, Chan L.
    J Cell Biochem; 2003 Aug 01; 89(5):1019-29. PubMed ID: 12874835
    [Abstract] [Full Text] [Related]

  • 11. The degradation of apolipoprotein B100 is mediated by the ubiquitin-proteasome pathway and involves heat shock protein 70.
    Fisher EA, Zhou M, Mitchell DM, Wu X, Omura S, Wang H, Goldberg AL, Ginsberg HN.
    J Biol Chem; 1997 Aug 15; 272(33):20427-34. PubMed ID: 9252351
    [Abstract] [Full Text] [Related]

  • 12. The amino-terminal domain of apolipoprotein B does not undergo retrograde translocation from the endoplasmic reticulum to the cytosol. Proteasomal degradation of nascent apolipoprotein B begins at the carboxyl terminus of the protein, while apolipoprotein B is still in its original translocon.
    Liang S, Wu X, Fisher EA, Ginsberg HN.
    J Biol Chem; 2000 Oct 13; 275(41):32003-10. PubMed ID: 10922368
    [Abstract] [Full Text] [Related]

  • 13. Ubiquitin-proteasome pathway mediates intracellular degradation of apolipoprotein B.
    Yeung SJ, Chen SH, Chan L.
    Biochemistry; 1996 Oct 29; 35(43):13843-8. PubMed ID: 8901527
    [Abstract] [Full Text] [Related]

  • 14. Distribution, transport, and degradation of apolipoprotein B-100 in HepG2 cells.
    Sakata N, Phillips TE, Dixon JL.
    J Lipid Res; 2001 Dec 29; 42(12):1947-58. PubMed ID: 11734567
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Transmembrane lipid transfer is crucial for providing neutral lipids during very low density lipoprotein assembly in endoplasmic reticulum.
    Higashi Y, Itabe H, Fukase H, Mori M, Fujimoto Y, Takano T.
    J Biol Chem; 2003 Jun 13; 278(24):21450-8. PubMed ID: 12670935
    [Abstract] [Full Text] [Related]

  • 17. Translocation efficiency, susceptibility to proteasomal degradation, and lipid responsiveness of apolipoprotein B are determined by the presence of beta sheet domains.
    Liang J, Wu X, Jiang H, Zhou M, Yang H, Angkeow P, Huang LS, Sturley SL, Ginsberg H.
    J Biol Chem; 1998 Dec 25; 273(52):35216-21. PubMed ID: 9857060
    [Abstract] [Full Text] [Related]

  • 18. Intracellular mechanisms regulating apoB-containing lipoprotein assembly and secretion in primary hamster hepatocytes.
    Taghibiglou C, Rudy D, Van Iderstine SC, Aiton A, Cavallo D, Cheung R, Adeli K.
    J Lipid Res; 2000 Apr 25; 41(4):499-513. PubMed ID: 10744770
    [Abstract] [Full Text] [Related]

  • 19. The triple threat to nascent apolipoprotein B. Evidence for multiple, distinct degradative pathways.
    Fisher EA, Pan M, Chen X, Wu X, Wang H, Jamil H, Sparks JD, Williams KJ.
    J Biol Chem; 2001 Jul 27; 276(30):27855-63. PubMed ID: 11285257
    [Abstract] [Full Text] [Related]

  • 20. Apolipoprotein B, a paradigm for proteins regulated by intracellular degradation, does not undergo intracellular degradation in CaCo2 cells.
    Liao W, Chan L.
    J Biol Chem; 2000 Feb 11; 275(6):3950-6. PubMed ID: 10660549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.